Basilea Pharmaceutica AG Stock
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
01:31:52 22/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 64.60 CHF | -1.52% |
|
+21.66% | +18.10% |
| 19/08 | Basilea Pharmaceutica Ag Raises Earnings Guidance for the Full Year 2026 | CI |
| 19/08 | Swiss Market Index Closes Higher; Huber+Suhner Shares Drop | MT |
| Market Cap | 801M 1B 856M 733M 1.38B 95.65B 1.39B 9.47B 3.69B 48.05B 3.75B 3.67B 159B | P/E 2026 * |
19x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 651M 812M 696M 596M 1.12B 77.73B 1.13B 7.69B 3B 39.05B 3.05B 2.98B 129B | EV / Sales 2026 * |
2.5x | EV / Sales 2027 * | 2.17x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| 1 day | -1.52% | ||
| 1 week | +21.66% | ||
| Current month | +24.47% | ||
| 1 month | +23.52% | ||
| 3 months | +21.20% | ||
| 6 months | +20.07% | ||
| Current year | +18.10% |
| 1 week | 53.2 |  | 65.9 |
| 1 month | 50.4 | | 65.9 |
| Current year | 47.8 | | 65.9 |
| 1 year | 44.7 | | 65.9 |
| 3 years | 32 | | 65.9 |
| 5 years | 29.55 | | 65.9 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/5/26 | Sell | -400 | 0.0030% | |||
| 25/2/26 | Fiscal year | 1,500 | 0.0113% | |||
| 20/2/26 | Sell | 600 | 0.0045% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.52% | +21.66% | +36.14% | +38.18% | 1B | |
| +1.09% | +5.26% | +4.52% | +26.24% | 51.61B | |
| -1.07% | +2.82% | +465.96% | +586.75% | 44.89B | |
| +1.47% | +9.79% | +35.92% | +21.40% | 42.77B | |
| +1.44% | +7.77% | +19.38% | +92.75% | 42.58B | |
| -0.93% | -4.33% | +16.18% | +53.76% | 31.82B | |
| +1.32% | +7.30% | +33.89% | +150.10% | 17.33B | |
| -0.60% | +1.93% | - | - | 16.63B | |
| +0.03% | +3.41% | +6.55% | +32.10% | 14.76B | |
| +1.28% | +5.41% | +82.40% | +47.43% | 14.09B | |
| Average | +0.25% | +6.16% | +77.88% | +116.52% | 27.75B | |
| Weighted average by Cap. | +0.48% | +4.78% | +99.33% | +145.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 261M 325M 279M 239M 448M 31.11B 454M 3.08B 1.2B 15.63B 1.22B 1.19B 51.7B | 271M 338M 289M 248M 465M 32.29B 471M 3.2B 1.25B 16.22B 1.27B 1.24B 53.66B |
| Net income | 53.56M 66.82M 57.24M 49.03M 92.01M 6.39B 93.22M 633M 247M 3.21B 251M 245M 10.62B | 44.43M 55.43M 47.48M 40.67M 76.33M 5.3B 77.34M 525M 205M 2.66B 208M 204M 8.81B |
| Net Debt | -150M -187M -160M -137M -258M -17.92B -261M -1.77B -691M -9B -703M -688M -29.77B | -214M -267M -228M -196M -367M -25.51B -372M -2.52B -985M -12.81B -1B -979M -42.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | CHF 64.60 | -1.52% | 73,634 |
| 20/08/26 | CHF 65.60 | +4.96% | 174,654 |
| 19/08/26 | CHF 62.50 | +4.87% | 207,024 |
| 18/08/26 | CHF 59.60 | +9.96% | 258,145 |
| 17/08/26 | CHF 54.20 | +2.07% | 26,954 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
